• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Celiac Disease Treatment Market

    ID: MRFR/HC/49598-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South Korea Celiac Disease Treatment Market Research Report By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End User (Hospitals and Clinics, Research Centers, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Celiac Disease Treatment Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    South Korea Celiac Disease Treatment Market Summary

    The South Korea Celiac Disease Treatment market is projected to grow significantly from 15.2 USD Million in 2024 to 49.5 USD Million by 2035.

    Key Market Trends & Highlights

    South Korea Celiac Disease Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 11.31 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 49.5 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 15.2 USD Million, reflecting the current demand for celiac disease treatments in South Korea.
    • Growing adoption of gluten-free products due to increasing awareness of celiac disease is a major market driver.

    Market Size & Forecast

    2024 Market Size 15.2 (USD Million)
    2035 Market Size 49.5 (USD Million)
    CAGR (2025-2035) 11.31%

    Major Players

    Yuhan Corporation, Korean Medicine Co, JW Pharmaceutical, Daewoong Pharmaceutical, DongA ST, Medytox, Boryung Pharmaceutical, Hanmi Pharmaceutical, Bio Proton, AhnGook Pharmaceutical, Pharmicell, Chong Kun Dang Pharmaceutical, LG Chem, Samyang Biopharmaceuticals

    South Korea Celiac Disease Treatment Market Trends

    In South Korea, the Celiac Disease Treatment Market is experiencing several significant trends driven by the growing awareness of gluten-related disorders and the rise in diagnoses of celiac disease. Increasing prevalence of the disease, as reported by local medical institutions and health organizations, is pushing the demand for effective treatment options and gluten-free products. This awareness is further enhanced by education campaigns from both governmental health entities and patient advocacy groups that emphasize the importance of strict adherence to a gluten-free lifestyle. 

    The trend towards functional foods and dietary supplements is also gaining momentum as consumers seek options that cater to their dietary restrictions while addressing their nutritional needs.The government of South Korea has actively supported dietary research as well as the development of gluten-free alternatives. This helps domestic producers increase their innovations and diversify their product lines. Furthermore, partnerships within the food industry and the healthcare sector promise new opportunities for specialized product development for celiac disease sufferers. 

    Recently, there has been growing interest in online and e-commerce platforms for the distribution of gluten-free products, making them more accessible to consumers throughout South Korea. Additionally, this phenomenon, along with the opening of specialized health food stores and supermarkets with gluten-free sections, indicates a deeper transformation towards a proactive dietary and health management culture.

    Furthermore, increased insurance coverage for celiac disease diagnosis and treatment is anticipated to play a crucial role in expanding the accessibility of treatment options in the region, thereby driving the market growth. Overall, the South Korean Celiac Disease Treatment Market is navigating a blend of heightened awareness, increased product availability, and supportive health policies, which collectively open new avenues for innovation and access in the treatment landscape.

    Market Segment Insights

    South Korea Celiac Disease Treatment Market Segment Insights

    South Korea Celiac Disease Treatment Market Segment Insights

    Celiac Disease Treatment Market Treatment Type Insights

    Celiac Disease Treatment Market Treatment Type Insights

    In the South Korea Celiac Disease Treatment Market, the Treatment Type segment plays a pivotal role in shaping the therapeutic landscape for individuals suffering from this condition. The market is primarily driven by the necessity for effective management strategies that cater to the unique dietary and health needs of patients with celiac disease. One of the key approaches is the Gluten Free Diet, which forms the cornerstone of treatment for celiac disease. Adhering to a strict gluten-free diet not only alleviates symptoms but also plays a significant role in promoting the overall health and well-being of patients. 

    The rising awareness regarding the adverse effects of gluten among South Koreans has catalyzed a growing demand for gluten-free food products in supermarkets and restaurants, indicating a cultural shift towards healthier dietary choices.Additionally, Vitamin and Minerals Supplements are also an important aspect of treatment, considering that individuals with celiac disease often experience nutrient malabsorption. As the population gains a deeper understanding of how celiac disease can lead to nutritional deficiencies, the demand for these supplements continues to rise, indicating an opportunity for product development in this segment. 

    Medical therapies are emerging as an innovative avenue for treatment, with ongoing Research and Development efforts aimed at finding alternative solutions beyond traditional dietary management. Such therapies could offer promise for those who struggle with food restrictions or who have not achieved satisfactory health improvements through diet alone. As the South Korea Celiac Disease Treatment Market evolves, there will be increased investments in these treatment options, underscoring the need for multifaceted approaches to effectively manage this condition.Furthermore, the South Korean government has indicated interest in supporting health initiatives aimed at addressing chronic diseases, including celiac disease. 

    This policy landscape may foster collaborations between healthcare providers, governmental bodies, and food manufacturers, resulting in improved access to gluten-free products and nutritional supplements. Market participants will need to navigate challenges such as regulatory compliance and consumer education concerning dietary needs in celiac disease management. Overall, the Treatment Type segment is vital for the South Korea Celiac Disease Treatment Market, as it encapsulates the diverse pathways through which patients can achieve better health outcomes, influenced considerably by cultural, nutritional, and medical factors.

    Celiac Disease Treatment Market End User Insights

    Celiac Disease Treatment Market End User Insights

    The South Korea Celiac Disease Treatment Market is segmented based on End User, revealing a diverse landscape that plays a crucial role in addressing this health condition. Hospitals and Clinics form a significant portion of this market segment, providing essential diagnostic and therapeutic services for patients suffering from celiac disease. These facilities are equipped with specialized teams capable of delivering tailored treatments, which is vital for effective management of the disorder. Research Centers are also noteworthy players in this market, as they contribute to the advancement of innovative therapies and understandings of celiac disease.

    They often undertake critical studies that help in formulating new treatment guidelines and improving patient outcomes. Additionally, the Others category includes community health organizations and patient advocacy groups that support awareness and education, further enhancing overall treatment and management. The combined efforts of these end users reflect a robust approach to tackling celiac disease in South Korea, driven by increasing prevalence and awareness of gluten sensitivity among the population. This comprehensive network underscores the importance of collaboration across various sectors to improve the quality of life for affected individuals and optimize treatment pathways.

    Get more detailed insights about South Korea Celiac Disease Treatment Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The competitive landscape of the South Korea Celiac Disease Treatment Market is characterized by a variety of key players, each contributing to the advancement of treatment options and solutions for managing celiac disease. This market is increasingly driven by a growing awareness of celiac disease among healthcare providers and patients alike, leading to an enhanced focus on innovative treatments and dietary solutions that meet the specific needs of those affected. 

    As consumers become more informed about the implications of celiac disease and the importance of adherence to a gluten-free lifestyle, companies in this market are compelled to innovate and effectively communicate the benefits of their products. The competition is intensified by rapid advancements in research and development, regulatory approvals, and the integration of cutting-edge technologies in treatment methodologies.Yuhan Corporation holds a notable position in the South Korea Celiac Disease Treatment Market due to its strong commitment to research and development.

    The company is renowned for its extensive experience in the pharmaceutical sector, which facilitates the creation of specialized products that cater to patients with celiac disease. 

    With a robust portfolio that emphasizes both innovative therapies and educational initiatives for gluten-free diets, Yuhan Corporation effectively engages healthcare professionals and patients. Its established distribution networks across South Korea enable the company to maintain a prominent presence within the market, ensuring timely access to essential treatments.

    The emphasis on quality and efficacy, coupled with strategic partnerships and collaborations within the healthcare ecosystem, further enhances Yuhan Corporation's standing in this competitive environment.Korean Medicine Co. is another significant player in the South Korea Celiac Disease Treatment Market, known for its dedication to traditional and modern therapeutic solutions tailored for individuals affected by celiac disease. 

    The company offers a range of products, including herbal formulations and gluten-free nutritional supplements, aimed at supporting patients in managing their symptoms and overall health. Korean Medicine Co. is recognized for its strong market presence, bolstered by effective marketing strategies and consumer education programs focused on the importance of gluten-free living. The company has made strides in merger and acquisition activities to expand its product offerings and foster innovation within its operations.

    Through these endeavors, Korean Medicine Co. solidifies its commitment to enhancing the quality of life for individuals with celiac disease while contributing to the overall growth and development of the treatment landscape in South Korea.

    Key Companies in the South Korea Celiac Disease Treatment Market market include

    Industry Developments

    In recent months, the South Korea Celiac Disease Treatment Market has seen significant developments, particularly with a focus on innovative therapeutics and enhanced patient support services. There has been increased collaboration among major companies like Yuhan Corporation, JW Pharmaceutical, and Hanmi Pharmaceutical to develop advanced treatments and diagnostic tools for celiac disease. In September 2023, Yuhan Corporation announced successful outcomes from its clinical trials for a promising therapeutic candidate aimed at celiac disease, strengthening its market position. 

    Furthermore, in July 2023, JW Pharmaceutical and Boryung Pharmaceutical expanded their Research and Development collaborations to address unmet needs in celiac disease treatment.The market has also witnessed a growing public awareness campaign led by DongA ST, aiming to educate patients about gluten-free diets and ongoing treatment options. The Celiac Disease Treatment Market in South Korea is projected to experience notable growth, driven by the increasing incidence of the disease and a rise in healthcare spending. In addition, the government is fostering initiatives to promote policy adjustments benefiting those with celiac disease, enhancing the overall support infrastructure in the country.

    Market Segmentation

    Outlook

    • Hospitals and Clinics
    • Research Centers
    • Others

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 13.74(USD Million)
    MARKET SIZE 2024 15.25(USD Million)
    MARKET SIZE 2035 49.55(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 11.307% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Yuhan Corporation, Korean Medicine Co, JW Pharmaceutical, Daewoong Pharmaceutical, DongA ST, Medytox, Boryung Pharmaceutical, Hanmi Pharmaceutical, Bio Proton, AhnGook Pharmaceutical, Pharmicell, Chong Kun Dang Pharmaceutical, LG Chem, Samyang Biopharmaceuticals
    SEGMENTS COVERED Treatment Type, End User
    KEY MARKET OPPORTUNITIES Rising awareness of celiac disease, Growth in gluten-free products, Development of novel therapeutics, Enhancement of diagnostic tools, Increased healthcare spending on treatments
    KEY MARKET DYNAMICS rising prevalence of celiac disease, increasing awareness and diagnosis, demand for gluten-free products, advancements in treatment options, growing healthcare expenditure
    COUNTRIES COVERED South Korea

    FAQs

    What is the expected market size of the South Korea Celiac Disease Treatment Market in 2024?

    The South Korea Celiac Disease Treatment Market is expected to be valued at 15.25 million USD in 2024.

    What will be the market size of the South Korea Celiac Disease Treatment Market by 2035?

    By 2035, the market is expected to grow significantly to 49.55 million USD.

    What is the expected compound annual growth rate (CAGR) for the South Korea Celiac Disease Treatment Market from 2025 to 2035?

    The market is projected to have a CAGR of 11.307% during the period from 2025 to 2035.

    Which segment of treatment type is expected to dominate the South Korea Celiac Disease Treatment Market in 2035?

    In 2035, the Gluten Free Diet segment is anticipated to dominate, valuing at approximately 21.56 million USD.

    What is the expected market value for Vitamin and Minerals Supplements in 2024?

    The market for Vitamin and Minerals Supplements is projected to be valued at 4.5 million USD in 2024.

    Which are the major players in the South Korea Celiac Disease Treatment Market?

    Key players in the market include Yuhan Corporation, JW Pharmaceutical, and Hanmi Pharmaceutical among others.

    How much is the Medical Therapies segment expected to be valued in 2035?

    The Medical Therapies segment is expected to reach approximately 13.79 million USD by 2035.

    How is the growth rate for the Gluten Free Diet segment projected from 2025 to 2035?

    The Gluten Free Diet segment is expected to experience substantial growth, contributing to the overall market expansion.

    What challenges might affect the growth of the South Korea Celiac Disease Treatment Market?

    Challenges could include market entry barriers and competition among various treatment types.

    What are the emerging trends expected to influence the South Korea Celiac Disease Treatment Market?

    Emerging trends include the increased awareness of celiac disease and the growing demand for gluten-free products.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials